RecruitingNCT04352036
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
Sponsor
Nantes University Hospital
Enrollment
465 participants
Start Date
Jan 4, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Our primary objective with this cohort will be to define the different phenotypes of acute hidrosadenitis, the characterization of which is essential to define suitable therapeutic approaches. Indeed, our recent data allow us to note that there would be different phenotypes of acute hidrosadenitis and therefore different pathologies inducing different follow-ups and care.
Eligibility
Inclusion Criteria2
- Patient diagnosed with acute hidrosadenitis by a dermatologist
- Patient agreeing to be part of the study
Exclusion Criteria2
- Major under guardianship
- Protected persons
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERno interventional study
no interventional study
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04352036